Mega Contracts Monitor ($100M+) — September 22, 2026

QTC Medical Services Inc., a Leidos subsidiary, received a $240.6 million firm-fixed-price delivery order from the VA for medical evaluation/screening services, with $233.6 million (97%) already outlayed. This indicates high utilization and potential for follow-on work, but also marks the end of the current contract period.

Leidos' revenue from this VA contract is concentrated in a single one-year delivery order with no options. The contract period ended September 30, 2024, and there is no evidence of follow-on awards, creating a revenue gap risk for Leidos if not replaced.

The VA's spending on medical evaluations is subject to federal budget cycles and potential continuing resolutions, which could delay or reduce future contract awards. The contract was awarded in September 2023, and future funding is not guaranteed.

The VA's sustained spending on medical evaluation services, evidenced by this $240.6 million contract, suggests a stable or growing market for healthcare services. Leidos, through QTC, is well-positioned to capture follow-on work or new contracts in this space.

The VA's award of a $240.6 million contract for medical evaluations underscores the agency's consistent demand for outsourced healthcare services, even as defense spending dominates federal procurement headlines.

{"entity" => "Leidos Holdings", "reason" => "Leidos' QTC subsidiary has a significant VA contract that has ended; future revenue depends on follow-on awards.", "trigger" => "VA announcement of new medical evaluation task orders or re-compete"}